Agilent Technologies Inc. (A)

Agilent Technologies Inc. (A $125.66)
- $125.66 P/E (TTM): 30.95X Cap: $35.69B
- View A Profile
- View Questions on A

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Agilent Technologies Inc. (A $125.66)
- $125.66 P/E (TTM): 30.95X Cap: $35.69B
- View A Profile
- View Questions on A
Harvest Healthcare Leaders Enhanced Income ETF (HHLE $8.69)
- $8.69 P/E (TTM): 72.11X Cap: $59M
- View HHLE Profile
- View Questions on HHLE

Q: HHLE (Harvest Healthcare Leaders Enhanced) is classified as "diverse", Yes, it is an ETF but it holds only healthcare companies and no industrial, yet it split between HealthCare and industrial. It is not included in the healthcare profile as a percentage of holdings. This put healthcare lower than it should be. Can this be adjusted or does HHLE deserve to be split between healthcare and industrial?

Read Answer Asked by STANLEY on September 11, 2024

Agilent Technologies Inc. (A $125.66)
- $125.66 P/E (TTM): 30.95X Cap: $35.69B
- View A Profile
- View Questions on A
Revvity Inc. (RVTY $90.11)
- $90.11 P/E (TTM): 38.51X Cap: $10.28B
- View RVTY Profile
- View Questions on RVTY

Q: What is your opinion on Revvity, including their forward PE. Is there any other company in this sector that you prefer. Thanks for your advice.

Read Answer Asked by Ian on December 20, 2023

Agilent Technologies Inc. (A $125.66)
- $125.66 P/E (TTM): 30.95X Cap: $35.69B
- View A Profile
- View Questions on A
Merck & Company Inc. (MRK $84.12)
- $84.12 P/E (TTM): 12.26X Cap: $210.11B
- View MRK Profile
- View Questions on MRK
Stryker Corporation (SYK $391.41)
- $391.41 P/E (TTM): 51.84X Cap: $149.63B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $492.72)
- $492.72 P/E (TTM): 28.5X Cap: $186.05B
- View TMO Profile
- View Questions on TMO
Visa Inc. (V $351.78)
- $351.78 P/E (TTM): 34.35X Cap: $682.43B
- View V Profile
- View Questions on V
Great-West Lifeco Inc. (GWO $54.40)
- $54.40 P/E (TTM): 13.6X Cap: $50.30B
- View GWO Profile
- View Questions on GWO
WSP Global Inc. (WSP $279.68)
- $279.68 P/E (TTM): 45.51X Cap: $36.50B
- View WSP Profile
- View Questions on WSP
- View Reports on WSP
Brown & Brown Inc. (BRO $96.95)
- $96.95 P/E (TTM): 27.94X Cap: $31.97B
- View BRO Profile
- View Questions on BRO
IDEX Corporation (IEX $164.50)
- $164.50 P/E (TTM): 26.62X Cap: $12.50B
- View IEX Profile
- View Questions on IEX

Q: For a TFSA if you could pick a few value stocks that have good balance sheets and maybe provide a “margin of safety” if we did have a recession, but also show some promising upside in the medium term if the stars align what would they be? (I’m agnostic on sector and cap size, US or Canada)
Thank you

Read Answer Asked by Stephen R. on June 28, 2023